T&CT announces the establishment of its first international branch with the opening of T&CT (UAE) based in Dubai’s Healthcare City. T&CT’s plans for a limited pilot and launch of new operations in the region were delayed due to the Covid19 outbreak, but with restrictions starting to ease, T&CT has formally commenced the process of bringing…
A major new clinical trial looking into the efficacy of an allogeneic topically applied solution to promote hair regrowth has shown clear and significant improvement in both hair count and hair diameter. The clinical study, undertaken by a reputed in South Korea’s Pusan National University School of Medicine, used mesenchymal Stem Cells (MSC’s) and Adipose-derived…
T&CT is pleased to announce that its close relationship with Hairclone Ltd is continuing to strengthen with the announcement that both companies are now collaborating on a number of new R&D initiatives using T&CT’s proprietary technology in the fields of adipose and tissue handling, as well as Adipose derived Stem Cells (ADRC’s), to further explore…
As the Chief Medical Officer for England has stated: NHS services nationally are likely to come under intense pressure as COVID-19 (coronavirus) spreads. Therefore, in line with well-established plans for situations like this, every hospital in England has been asked to suspend all elective (non-urgent) operations from 15 March 2020 for at least three months,…
T&CT is pleased to announce that our regular inspection by the Human Tissues Authority has again passed without a hitch. A copy of the report and findings are available on the HTA website, or we can send you copy on request.